Sugi Predict

Sugi Predict / Compounds / SCHEMBL1674876

SCHEMBL1674876

SCHEMBL1674876

NCCCC[C@H](NC(=O)OCc1ccccc1)C(=O)Nc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SSTR3 P32745 1/20 0.64
▸ PDF Q9HBH1 1/20 0.57
▸ SIRT2 Q8IXJ6 9/20 0.56
▸ SIRT1 Q96EB6 8/20 0.56
▸ SIRT5 Q9NXA8 3/20 0.56
▸ SIRT3 Q9NTG7 3/20 0.54
▸ MMP3 P08254 1/20 0.53
▸ HDAC1 Q13547 2/20 0.52
▸ HDAC2 Q92769 2/20 0.52
▸ TGM2 P21980 1/20 0.52
▸ HDAC3 O15379 1/20 0.52
▸ HDAC4 P56524 1/20 0.52
▸ HDAC7 Q8WUI4 1/20 0.52
▸ HDAC10 Q969S8 1/20 0.52
▸ HDAC11 Q96DB2 1/20 0.52
▸ HDAC8 Q9BY41 1/20 0.52
▸ HDAC6 Q9UBN7 1/20 0.52
▸ HDAC9 Q9UKV0 1/20 0.52
▸ HDAC5 Q9UQL6 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17742350 0.89 SIRT2 (0.69) SIRT2SIRT1SIRT5SIRT3MMP3
SCHEMBL8433172 0.88 HDAC1 (0.65) SSTR3HDAC1HDAC2TGM2
SCHEMBL8205341 0.87 SIRT5 (0.57) SIRT2SIRT1SIRT5MMP3HDAC1
SCHEMBL29897716 0.87 SIRT1 (0.60) SSTR3SIRT2SIRT1SIRT5SIRT3
SCHEMBL4261994 0.87 SSTR3 (0.59) SSTR3PDFSIRT5MMP3
SCHEMBL2268022 0.86 SIRT5 (0.57) SSTR3SIRT2SIRT1SIRT5SIRT3
SCHEMBL6287961 0.86 SIRT2 (0.60) SIRT2SIRT1SIRT5SIRT3MMP3
SCHEMBL4011349 0.86 F2 (0.64) HDAC8
Hydrochloric Acid SCHEMBL10884941 0.85 SIRT5 (0.56) SSTR3SIRT2SIRT1SIRT5SIRT3
Hydrochloric Acid SCHEMBL10943848 0.85 SIRT5 (0.56) SSTR3SIRT2SIRT1SIRT5SIRT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260083142-A1 DRIED FLAKES WITH ACTIVE INGREDIENTS FLAVORSENSE (US) 2026-03-26 — — US disclosed
US-12310379-B2 Dried flakes with active ingredients FLAVORSENSE (US) 2025-05-27 — — US disclosed
EP-4548775-A2 GOLD KIWIFRUIT COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREFOR Anagenix IP Limited (NZ) 2025-05-07 — — EP disclosed
EP-3223838-B1 GOLD KIWIFRUIT COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREFOR ANAGENIX IP LTD (NZ) 2025-02-05 — — EP disclosed
US-12168030-B2 Method for producing stable Actinidia deliciosa powder with high level bioactive actinidin enzyme WAITAKI BIOSCIENCES (NZ) 2024-12-17 — — US disclosed
US-20240091291-A1 GOLD KIWIFRUIT COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREFOR ANAGENIX IP LTD (NZ) 2024-03-21 — — US disclosed
US-20230292797-A1 DRIED FLAKES WITH ACTIVE INGREDIENTS FLAVORSENSE 2023-09-21 — — US disclosed
US-11642386-B2 Gold kiwifruit compositions and methods of preparation and use therefor ANAGENIX IP LIMITED (NZ) 2023-05-09 — — US disclosed
US-11533936-B2 Dried flakes with active ingredients FLAVORSENSE (US) 2022-12-27 — — US disclosed
EP-4099841-A1 METHOD FOR PRODUCING STABLE ACTINIDIA DELICIOSA POWDER WITH HIGH LEVEL BIOACTIVE ACTINIDIN ENZYME Waitaki Biosciences (NZ) 2022-12-14 — — EP disclosed
US-6129917-A Immunogenic compositions comprising porphyromonas gingivalis proteins and/or peptides and methods THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2000-10-10 — — US disclosed
EP-1017714-A1 SYNTHETIC PEPTIDE CONSTRUCTS FOR THE DIAGNOSIS AND TREATMENT OF PERIODONTITIS ASSOCIATED WITH $i(PORPHYROMONAS GINGIVALIS) THE UNIVERSITY OF MELBOURNE (AU) 2000-07-12 — — EP disclosed
US-6017532-A A PURE HIGH MOLECULAR WEIGHT ARGINE-GINGIPAIN PREPARATION COMPRISING AN ENZYMATICALLY ACTIVE PROTEASE COMPONENT AND A NONCOVALENTLY ASSOCIATED HEMAGGLUTININ; ORAL DISEASE, E.G., GINGIVITIS;VACCINES UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2000-01-25 — — US disclosed
WO-1998049192-A1 SYNTHETIC PEPTIDE CONSTRUCTS FOR THE DIAGNOSIS AND TREATMENT OF PERIODONTITIS ASSOCIATED WITH $i(PORPHYROMONAS GINGIVALIS) THE UNIVERSITY OF MELBOURNE (AU) 1998-11-05 — — WO disclosed
US-5707620-A Lysine-specific Porphyromonas gingivalis proteinase UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 1998-01-13 — — US disclosed
WO-1997033984-A1 NOVEL ACHROMOBACTER LYTICUS PROTEASE VARIANTS NOVO NORDISK A/S (DK) 1997-09-18 — — WO disclosed
EP-0717747-A1 PORPHYROMONAS GINGIVALIS ARGININE-SPECIFIC PROTEINASE CODING SEQUENCES THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 1996-06-26 — — EP disclosed
US-5523390-A RECOMBINANT DNA MOLECULE COMPRISING NUCLEOTIDE SEQUENCE ENCODING PROTEIN WITH GIVEN AMINO ACID SEQUENCE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 1996-06-04 — — US disclosed
US-5475097-A Recombinant DNA comprising nucleotide sequence encoding lysine gingipain protein complex UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 1995-12-12 — — US disclosed
WO-1995007286-A1 PORPHYROMONAS GINGIVALIS ARGININE-SPECIFIC PROTEINASE CODING SEQUENCES UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 1995-03-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260083142-A1 DRIED FLAKES WITH ACTIVE INGREDIENTS COG1, COG5, COG3 SSTR3 2525/4885PDF 4104/4885SIRT2 3050/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.